Voyager Therapeutics, Inc. (NASDAQ: VYGR)
$6.8500
+0.0100 ( +0.15% ) 151.1K
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Market Data
Open
$6.8500
Previous close
$6.8400
Volume
151.1K
Market cap
$373.01M
Day range
$6.6420 - $7.0170
52 week range
$5.7100 - $11.7200
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
8-k | 8K-related | 20 | Jan 08, 2024 |
8-k | 8K-related | 12 | Jan 02, 2024 |
8-k | 8K-related | 14 | Dec 06, 2023 |
8-k | 8K-related | 14 | Nov 06, 2023 |
10-q | Quarterly Reports | 63 | Nov 06, 2023 |
4 | Insider transactions | 1 | Oct 05, 2023 |
4 | Insider transactions | 1 | Oct 02, 2023 |